II. Supplementary table
. List of primers used in the present study
5' and 3' RACE

Target
Primer Sequence
Strand-specific RT-qPCR
Target
INXS
Sense/Forward CCCCCTCCAGGTACCAGAAC Antisense/Reverse CCACTGGTGCTTTCGATTTGA 
RT-qPCR of total BCL-X, of BCL-X isoforms and of controls and normalizers
III. Supplementary materials and methods
Cell culture 
RT-qPCR
For the absolute quantification of INXS lncRNA across the different cell lines in Figure 1C For the experiments of Figure 1B and Figure 7A we used strand-specific RT as BCL-X mRNA, independent of the isoforms, a pair of primers was designed to target a sequence on exon 2 that is common to both isoforms. The primer sequences are listed in Table S1 . 
Biogenesis by RNA polymerase II, 5'-cap structure and stability assays
To test for the presence of a methylguanosine 5'-cap modification in INXS, total RNA (10 µg)
from HeLa cells was treated with 1 unit Terminator 5'-phosphate-dependent exonuclease (5-Exo, Epicentre) for 2 h at 30°C, with or without prior treatment with 10 units tobacco acid pyrophosphatase (TAP) for 1 h at 37°C, according to the manufacturer's protocol. After exonuclease treatment, qPCR for INXS was performed. TUBA1C tubulin gene was assayed as a control. The results were normalized using the level of SNORD15A snoRNA, a noncapped RNA (4) . The primers used are listed in Table S1 .
For RNA Polymerase II inhibition and RNA decay assays, 5x10 5 cells were cultured for 24 h. Subsequently, for the RNAP II inhibition assays, the medium was replaced by fresh medium with 50 µg/ml α-amanitin (Sigma) or vehicle (water) and maintained for 9h. For the RNA decay assay, the culture medium was replaced by medium with 10 µg/ml actinomycin D Table S1 .
Cell fractionation
Nuclear and cytoplasmic fractionation and RNA isolation were performed as previously described (5) . The RNA was used for reverse transcription and qPCR as described above.
The results were normalized relative to the level of GAPDH detected in the same fraction, either cytoplasmic or nuclear (6) . Adequate cell fractionation was controlled by separating the total RNA extract of the fractions by electrophoresis in the BioAnalyzer (Agilent) and
detecting the presence of a 32S rRNA band exclusively in the nuclear fraction (7) . Additionally, 
Induction of endogenous INXS expression
Cells (786-O) on 100-mm plates were exposed to UV-C for 40 s at 1 J.m-2 .s -1 immediately following the replacement of the culture medium by PBS, and subsequently grown in culture medium with 10% serum for up to 24 h. For INXS knockdown followed by UV-C induction, 60mm plates were used, and knockdown (see below) was carried out prior to UV-C exposure.
For the serum reduction assay, cells were grown for 24 h with different serum concentrations, as indicated in the figures. For SFN treatment, 50µM DL-sulforaphane (Sigma) was added to cells in DMEM medium with 10% serum and cultured for up to 24 h.
Promoter assay
Putative promoter sequences were amplified from genomic DNA (primers are listed in Table   S1 ) and cloned into pGL3-basic vector in the direct (pGL3-antisense) or inverted (pGL3inverted) orientation. A Dual-Luciferase Reporter Assay System (Promega) was used with HEK293 cells according to the manufacturer's protocol.
Transient plasmid transfection
The INXS full-length cDNA was cloned into the NheI and XhoI sites of pCEP4 expression vector (Invitrogen), and it was sequence-verified. The cells were transfected with pCEP4-INXS or with empty vector, using 1 µg of plasmid per 10 6 cells and FuGENE HD (Promega), and grown for 24 h prior to qPCR or apoptosis assays. For the time-course assay, cells were transfected with 1 µg of plasmid per 10 6 cells and FuGENE HD (Promega), and grown for the indicated periods of time prior to qPCR. For the plasmid titration assay, the cells were transfected with the different amounts of plasmid that are indicated in the figures, and the assay was carried out after 12 h.
Oligonucleotide transfection
For silencing of INXS lncRNA, the cells were plated for 24 h in 60 mm-diameter plates in OPTI-MEM (Invitrogen) medium. Subsequently, two distinct modified 20-mer oligos (500 nM, final concentration, IDT) targeting INXS or a modified scrambled oligo (IDT) were separately transfected using lipofectamine RNAimax (Invitrogen); total RNA was extracted 24 h after transfection. Oligonucleotide sequences are listed in Table S1 .
We Figure S5A ). In parallel, we observed a progressive change in the BCL-X isoforms, and a progressive reduction in the BCL-XS/BCL-XL ratio with increasing ASOs (Figure S5B) . Again, the most effective reduction was obtained with the combination of ASO-1 plus ASO-2 at 200 nM; a similar extent of reduction was obtained for each of the two ASOs separately, at 500 nM each (see Figure 5 in the main text).
Note that in spite of obtaining a pronounced INXS knockdown effect with the combination of ASO-1 plus ASO-2 at 200 nM, we have favored the ability to test the two distinct ASOs separately, in order to be able to collect independent evidence of phenotypic effects elicited for each of the two distinct ASOs, which adds to the evidence of a specific effect related to INXS knockdown. Therefore, for further tests with the three apoptosisinducing agents (UV-C, serum starvation and sulforaphane, in Figure 5 ) we used each ASO separately at 500 nM concentration (8) , rather than testing the two ASOs in combination.
Fluorimetric determination of caspase activity
Four million cells were washed twice with PBS, and lysed in 50 µl of ice-cold lysis buffer (150 mM NaCl, 20 mM Tris pH 7.5, 1% Triton X-100, 10 µg/ml leupeptin, 5 µg/ml aprotinin and 100 µM PMSF). The cell lysates were incubated on dry ice for 1 min, followed by 10 min incubation at 4°C, and supernatants were obtained by centrifugation at 15,000 g for 15 min at Reverse transcription and qPCR were performed with these samples, as described in the main text.
Western blotting analysis
In parallel with the RIP assay, the immunoprecipitated proteins attached to the beads were analyzed by western blotting with anti-Sam68 antibody (Santa Cruz Biotechnology) using ECL detection reagents (Amersham, GE Healthcare). For this purpose, in the RIP procedures after the beads were washed and prior to the RNA extraction steps, 10% of the final volume containing the bead-antibody complexes from the RIP assay was saved to perform western blot and detect Sam68. The beads were suspended in Laemmli Sample Buffer and incubated at 95 °C for 5 min, then briefly spun down, and the supernatant was loaded on SDS-PAGE and run at 90V for 2 h. One percent of the cell lysate was separated before immunoprecipitation, and also loaded in parallel, as a control input. The proteins were transferred to a nitrocellulose membrane (Amersham, GE Healthcare), and were developed with anti-Sam68 antibody (Santa Cruz Biotechnology) at 1:200 dilution, using ECL western blotting detection reagents (Amersham, GE Healthcare). Autopsies were performed, and the tumors were weighed.
Fluorescence microscopy
For immunofluorescence experiments, cells transfected with pCEP4-INXS or pCEP4-empty were collected 24 h after transfection and fixed with 2% p-formaldehyde for 15min. The cells were plated on coverslips, incubated for 5 minutes with TBS-0.1% Triton X-100 for permeabilization and then blocked with TBS-0.1% Triton X-100 1% BSA for 1h at room temperature. Subsequently, the coverslips were incubated with anti-cleaved caspase 3 (Asp175) (5A1E) Rabbit mAb (9664, Cell Signaling) and anti-α-tubulin (sc-53646, Santa
Cruz Biotechnology) antibodies. The visualization of cleaved caspase 3 was performed with specific anti-IgG conjugated with Alexa Fluor-555 (A-21422, Molecular Probes) and the αtubulin with Alexa Fluor-488 (A-11001, Molecular Probes). The nuclear DNA was stained with 20µg/ml Hoechst 33342 (H1399, Invitrogen). The images were obtained on Nikon Eclipse E600 microscope and deconvoluted using the Huygens Essential software image processing.
In vivo optical imaging system
Tumors were monitored by near-infrared optical imaging using the Odyssey scanner (LI-COR, Biosciences). Mice were injected intravenously via tail vein with 1 nmol of IRDye 800CW EGF Optical Probe (LI-COR, Biosciences) dissolved in PBS per animal, and 12 h after injection the animals were scanned for in vivo fluorescence imaging according to the manufacturer's protocol.
Statistical tests
Data are represented as the mean ± SD. Statistical significance was calculated using a twoway ANOVA followed by the Bonferroni test as a post-test or using a two-tailed paired Student t-test. P<0.05 was considered significant, and statistical significance is denoted in the figures with one asterisk (P<0.05), two asterisks (P<0.01) or three asterisks (P<0.001).
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